3005-85-4 Usage
Uses
Used in Pharmaceutical Industry:
4-METHYL-2-PYRROLIDINE CARBOXYLIC ACID is used as a building block for the development of pharmaceutical drugs. Its unique properties as a chiral auxiliary in asymmetric synthesis make it a valuable component in the creation of enantiomerically pure compounds, which are essential in the pharmaceutical industry for the production of effective and safe medications.
Used in Organic Synthesis:
In the field of organic synthesis, 4-METHYL-2-PYRROLIDINE CARBOXYLIC ACID is utilized as a chiral auxiliary. Its ability to influence the stereochemistry of reactions allows for the selective formation of desired enantiomers, which is crucial in the synthesis of complex organic molecules with specific biological activities.
Used in Agricultural Industry:
4-METHYL-2-PYRROLIDINE CARBOXYLIC ACID is also studied for its potential use in the agricultural industry. It has been explored for its application in the development of crop protection products, where its unique properties may contribute to the creation of innovative and effective solutions for pest and disease control, ultimately benefiting crop yield and quality.
Check Digit Verification of cas no
The CAS Registry Mumber 3005-85-4 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 3,0,0 and 5 respectively; the second part has 2 digits, 8 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 3005-85:
(6*3)+(5*0)+(4*0)+(3*5)+(2*8)+(1*5)=54
54 % 10 = 4
So 3005-85-4 is a valid CAS Registry Number.
InChI:InChI=1/C6H11NO2/c1-4-2-5(6(8)9)7-3-4/h4-5,7H,2-3H2,1H3,(H,8,9)
3005-85-4Relevant academic research and scientific papers
Revised structure and structure-activity relationship of bisebromoamide and structure of norbisebromoamide from the marine cyanobacterium Lyngbya sp.
Sasaki, Hiroaki,Teruya, Toshiaki,Fukazawa, Hidesuke,Suenaga, Kiyotake
experimental part, p. 990 - 994 (2011/03/19)
Novel potent cytotoxic peptides bisebromoamide (1) and norbisebromoamide (2) have been isolated from the marine cyanobacterium Lyngbya sp. The planar structure of these peptides was elucidated through the extensive application of 1D and 2D NMR techniques. The absolute stereostructure of 1 was determined by chemical degradation followed by chiral HPLC analysis. Recently, Tao and co-workers achieved synthesis of bisebromoamide, and the configuration of thiazoline moiety was revised. We re-investigated the stereochemistry of thiazoline moiety of 1. The structure-activity relationships of bisebromoamide (1) were investigated with the use of natural and synthetic analogs. Furthermore, bisebromoamide (1) potently inhibited protein kinase: the phosphorylation of ERK in NRK cells by PDGF-stimulation was selectively inhibited by treatment with 10-0.1 μM of 1.
